Evaluation of Physician and Patient Knowledge of Safety and Safe Use Information for Aflibercept in Europe: An Observational Postauthorisation Study

19/06/2015
05/04/2024
EU PAS number:
EUPAS9991
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

EM_Protocol_Final after EMA review_v3_11 Feb 2015ENCePP

English (961.69 KB - PDF) View document
Study results
Study results

16526_EU-PAS_Abstract_CTP

English (61 KB - PDF) View document
Study report
Study report

16526_Eylea Europe RMS_Final Report_Bayer_15Nov2017

English (6.3 MB - PDF) View document
Other information